Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma

PURPOSE: We aimed to determine whether the pan-immune-inflammation value (PIV) of patients with Merkel cell carcinoma (MCC) at primary diagnosis differs from controls and whether it is associated with disease stage and outcome. METHODS: In this retrospective study, we recruited MCC patients with sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambichler, T., Said, S., Abu Rached, N., Scheel, C. H., Susok, L., Stranzenbach, R., Becker, J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508022/
https://www.ncbi.nlm.nih.gov/pubmed/35098389
http://dx.doi.org/10.1007/s00432-022-03929-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508022/
https://www.ncbi.nlm.nih.gov/pubmed/35098389
http://dx.doi.org/10.1007/s00432-022-03929-y

Ejemplares similares